Colgate Palmolive (CL) Receivables (2009 - 2026)

Colgate Palmolive's Receivables history runs 18 years deep, the most recent figure standing at $1.9 billion for Q1 2026.

• On a quarterly basis, Receivables rose 9.51% year-over-year to $1.9 billion in Q1 2026; TTM through Mar 2026 was $1.9 billion, a 9.51% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 10.12% from the prior year.
• Receivables grew to $1.9 billion in Q1 2026 per CL's latest filing, from $1.7 billion in the prior quarter.
• Across five years, Receivables topped out at $1.9 billion in Q1 2026 and bottomed at $1.4 billion in Q3 2022.
• The 5-year median for Receivables is $1.7 billion (2023), against an average of $1.7 billion.
• Across the five-year window, Receivables grew 15.96% in 2022 and slipped 4.85% in 2025, its largest moves.
• Year by year, Receivables stood at $1.5 billion in 2022, then increased by 5.45% to $1.6 billion in 2023, then fell by 4.1% to $1.5 billion in 2024, then gained by 10.12% to $1.7 billion in 2025, then climbed by 12.78% to $1.9 billion in 2026.
• Per Business Quant, the three latest CL Receivables figures stand at $1.9 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.8 billion (Q3 2025).